Search for: "Best Products, Inc. v. Best Products Co., Inc" Results 101 - 120 of 1,370
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Sep 2022, 9:01 pm by Gary Gensler
The point is, it is important to look at the facts and circumstances of a product, not its label, to determine whether it is a crypto security token, a crypto non-security token, or another instrument. [read post]
7 Sep 2022, 5:23 am by Eugene Volokh
State lawmakers are generally better positioned than federal lawmakers to ascertain such in-state preferences and implement the best policies based on them. [read post]
18 Jul 2022, 2:46 pm by Kevin LaCroix
Regular readers of this blog know my view that the  rise of collective investor actions outside the United States is one of the most important developments in the world of directors’ and officers’ liability in recent years. [read post]
19 Jun 2022, 4:44 pm by admin
The authors state the obvious; namely, toxicologic evidence is best suited to the assessment of general causation. [read post]
25 May 2022, 9:01 pm by Richard Zelichov and Trevor T. Garmey
Securities Litigation, 768 F.3d 1046 (9th Cir. 2014) (violations of Section 303 do not give rise to private right of action under Section 10(b) and Rule 10b-5) with Stratte-McClure v. [read post]
11 May 2022, 8:51 pm by Javier Dominguez
My clients were diverse, my colleagues were diverse and my co-counsel was diverse. [read post]
9 May 2022, 8:51 am by William C. MacLeod
Skelly Wright, the court cautioned: Our duty here is not simply to make a policy judgment as to what mode of procedure…best accommodates the need for effective enforcement of the Commission’s mandate…. [read post]